Gabrielle Roth-Guépin

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Edmond Chiche, Ramy Rahmé, Sarah Bertoli et al. · Blood Advances · 2021 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients

Annalisa Ruggeri, Gabrielle Roth-Guépin, Giorgia Battipaglia et al. · Transplant Infectious Disease · 2015 · 92 citations

Medicine, Hematology, Infectious Diseases +17

Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

Raynier Devillier, Myriam Labopin, Patrice Chevallier et al. · Bone Marrow Transplantation · 2018 · 41 citations · Full text

Medicine, Hematology, Immunology +17

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 ⁺ Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia

Thibaut Leguay, Marc Delord, Cyril Šálek et al. · Journal of Clinical Oncology · 2024 · 34 citations

Medicine, Hematology, Oncology +16

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT

Gabrielle Roth-Guépin, Jonathan Canaani, Annalisa Ruggeri et al. · Oncotarget · 2017 · 30 citations · Full text

Medicine, Hematology, Oncology +13